Alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease patients.

被引：0
|
作者：
Sarac, E [1 ]
Smavatkul, C [1 ]
Boolchand, V [1 ]
机构：
[1] St Elizabeth Hosp, NEUCOM, NE Ohio Coll Med, Youngstown, OH USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：794A / 794A
页数：1
相关论文
共 50 条
  • [1] Hemoglobin and hematocrit response for alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease
    Sarac, E
    Smavatkul, C
    Boolchand, V
    Gemmel, D
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A41 - A41
  • [2] Epoetin alfa and darbepoetin alfa dosing trends in pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, S
    Piech, CT
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 416 - 416
  • [3] Epoetin alfa and darbepoetin alfa dosing patterns in anemic pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, RS
    Bookhart, B
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A96 - A96
  • [4] Epoetin alfa and darbepoetin alfa dosing patterns and drug costs in patients with pre-dialysis chronic kidney disease
    Lefevbre, P
    Mody, SH
    McKenzie, RS
    Bookhart, B
    Duh, MS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [5] Epoetin alfa and darbepoetin alfa dosing trends and drug costs in elderly pre-dialysis chronic kidney disease patients
    Mody, S.
    Padmanabhan, V
    Bookhart, B.
    Mckenzie, R. S.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A12 - A13
  • [6] HEMATOLOGIC OUTCOMES AND DOSING PATTERNS IN ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) SWITCHING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Hura, Claudia
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    McKenzie, R. Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A65 - A65
  • [7] Hemoglobin Variability With Extended Dosing of Epoetin Alfa in Patients With Chronic Kidney Disease and Not on Dialysis
    Bailey, Robert A.
    McGowan, Tracy
    Tang, K. Linda
    Langholff, Wayne K.
    Lantz, Keith C.
    Wolfson, Marsha
    [J]. DIALYSIS & TRANSPLANTATION, 2009, 38 (10) : 407 - +
  • [8] Hospital inpatient utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in patients with cancer and pre-dialysis chronic kidney disease (PCKD)
    Smith, J
    He, J
    Mahoney, A
    Noone, P
    Watson, S
    Mody, S
    McKenzie, RS
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A105 - A105
  • [9] An examination of direct and indirect employer costs associated with epoetin alfa treatment in pre-dialysis chronic kidney disease patients
    Bookhart, Brahim K.
    Papatheofanis, Frank
    Chawla, Namrita
    Muser, Erik
    Piech, Catherine Tak
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A31 - A31
  • [10] EPOETIN ALFA AND DARBEPOETIN ALFA COSTS BY DOMINANT DOSING INTERVAL IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Bailey, Robert
    Tunceli, Ozgur
    Singer, Joseph
    Stephenson, Judith
    Senbetta, Mekre
    McKenzie, Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A23 - A23
12345